Search - Prime Therapeutics

411 Results for GLP-1 Pipeline Update

David Lassen shares insights on Prime/Magellan Rx analysis on GLP-1s for weight loss in new video

Following real-world analysis of GLP-1 drugs for weight loss, Prime/Magellan Rx releases new video about GLP-1 research

PA Sub-Categories: GLP-1 Prime Article: Stories
Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products

PA Sub-Categories: GLP-1 Prime Article: Press Releases
April Fraud Focus: How to identify counterfeit GLP-1 weight-loss drugs

Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common GLP-1 fraud schemes

PA Sub-Categories: GLP-1 Prime Article: Perspectives
Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Real-world study of GLP-1 patients continues to deliver leading insights

PA Sub-Categories: GLP-1 Prime Article: Press Releases